Documents & Downloads

Mopidralazine hydrochloride

Antihypertensive Agent

Mopidralazine hydrochloride is an orally active antihypertensive agent that primarily targets the regulation of blood pressure. It has been shown to significantly reduce systolic blood pressure in spontaneously hypertensive rat models, with an ED50 value of 1.94 mg/kg. Notably, Mopidralazine hydrochloride exhibits a slower onset of action along with a longer duration, while minimally affecting heart rate in canine models of renal hypertension. This compound is valuable for research applications focused on hypertension and cardiovascular physiology.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	86703-02-8
Applications	Antihypertensive Agent
Formula	C₁₄H₂₀ClN₅O
Molecular Weight	309.79
Synonyms	MDL-899
SMILES	CC1=CC=C(C)N1NC2=NN=C(N3CCOCC3)C=C2.Cl

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.